ESMO Gastrointestinal Cancers Congress 2025

CCIB – International Barcelona Convention Centre Plaça de Willy Brandt 11-14, Barcelona, Spain

The ESMO Gastrointestinal Cancers Congress 2025 is set for July 2-5 in Barcelona, Spain, with an online option available through a dedicated virtual platform. It is organized by the European Society For Medical Oncology. This

Best of ASCO Annual Meeting 2025

Hyatt Regency Minneapolis 1300 Nicollet Mall, Minneapolis, MN, United States

The Best of ASCO Annual Meeting will be held at the Hyatt Regency Minneapolis, in Minneapolis, on July 11-12, 2025, with an online option available. This two-day program is an Official Annual Meeting Review of

ESMO Targeted Anticancer Therapies Asia Congress 2025

The ESMO TAT Asia Congress 2025 will be held in Hong Kong SAR, China on July 18-20. This multi-stakeholder forum brings together key players in cancer drug development, providing a platform to share the latest advances

ASCO Breakthrough 2025

The ASCO Breakthrough 2025 is set to take place in Yokohama, Japan, with an online option available for participants worldwide, on August 7-9. This exciting event will focus on groundbreaking research and innovative advancements in

8th Translational Research Conference: Lymphoid Malignancies

8th Translational Research Conference: Lymphoid Malignancies will be held at Estoril, Portugal from October 2-4, 2025. ESH Translational Research Conferences focus on leading-edge basic, clinical and therapeutic research and future perspectives. A distinguished faculty of

World Cancer Leaders’ Summit 2025

The World Cancer Leaders’ Summit 2025 will take place in Melbourne, Australia, on November 18-20. This important event, held every two years, serves as a key forum for coordinating a global response to the growing

World Conference on Lung Cancer 2026

Seoul, South Korea Seoul

IASLC 2026 World Conference on Lung Cancer (WCLC), will be held from September 12-15, 2026, in Seoul, South Korea. The International Association for the Study of Lung Cancer (IASLC) is pleased to announce that it is